New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 29, 2014
10:26 EDTNJR, MANU, FIATY, DLR, CRZBD, WOPEY, NGG, AWAY, EDPFY, DSW, CELG, PAGP, MDAS, HSY, DG, CS, BMOOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Bank of Montreal (BMO) downgraded to Sector Perform from Outperform at RBC Capital... Celgene (CELG) downgraded to Neutral from Overweight at JPMorgan... Commerzbank (CRZBD) downgraded to Neutral from Outperform at Exane BNP Paribas... Credit Suisse (CS) downgraded to Neutral from Buy at BofA/Merrill... DSW (DSW) downgraded to Neutral from Positive at Susquehanna... Digital Realty (DLR) downgraded to Hold from Buy at Cantor... Dollar General (DG) downgraded at Sterne Agee... Energias de Portugal (EDPFY) downgraded to Sell from Neutral at Citigroup... Fiat (FIATY) downgraded to Underperform from Market Perform at Bernstein... Hershey (HSY) downgraded to Hold from Buy at Argus... HomeAway (AWAY) downgraded to Neutral from Overweight at JPMorgan... Manchester United (MANU) downgraded to Neutral from Overweight at JPMorgan... MedAssets (MDAS) downgraded to Neutral from Buy at Citigroup... National Grid (NGG) downgraded to Neutral from Outperform at Credit Suisse... New Jersey Resources (NJR) downgraded to Hold from Buy at Brean Capital... Plains GP Holdings (PAGP) downgraded to Equal Weight from Overweight at Stephens... Woodside Petroleum (WOPEY) downgraded to Market Perform from Outperform at Bernstei.
News For BMO;CELG;CRZBD;CS;DSW;DLR;DG;EDPFY;FIATY;HSY;AWAY;MANU;MDAS;NGG;NJR;PAGP;WOPEY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
November 19, 2014
06:39 EDTDGDollar General may have to sell over 4K stores for deal approval, NY Post says
The Federal Trade Commission may require Dollar General (DG) to sell more than 4,000 of its stores to gain approval of its deal to buy Family Dollar (FDO), according to The New York Post. Dollar General had previously said that it was willing to sell 1,500 of its stores to facilitate the deal, the newspaper stated. Reference Link
05:54 EDTNGGNational Grid upgraded to Hold from Sell at Deutsche Bank
Subscribe for More Information
November 18, 2014
17:37 EDTFIATYNHTSA wants 'millions of vehicles' recalled due to Takata air bags, CNBC reports
The National Highway Traffic Safety Administration, or NHTSA, is calling for a nationwide recall of "millions of vehicles" due to Takata air bags that could inflate with too much force and injure drivers, reports CNBC. The NHTSA stated that the agency will "use the full extent of its statutory powers" if the recall is not conducted quickly, CNBC added. Publicly traded companies in the space include Fiat S.p.A. (FIATY), Ford (F), General Motors (GM), Honda (HMC), Nissan (NSANY), Toyota (TM) and Volkswagen (VLKAY). Reference Link
09:34 EDTDLRDigital Realty downgraded to Equal Weight from Overweight at Morgan Stanley
07:34 EDTCELGCelgene presents long-term OTEZLA data at ACR/ARHP meeting
Celgene announced that results from long-term efficacy and safety analyses of OTEZLA from the open-label phase of two PALACE phase III clinical trials were presented at the 2014 American College of Rheumatology/Association of Rheumatology Health Professionals annual meeting in Boston. OTEZLA is the Company’s oral, selective inhibitor of phosphodiesterase 4, approved by the U.S. FDA for the treatment of adult patients with active psoriatic arthritis and for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. In PALACE 1, 84 percent of patients who completed one year of 30 mg twice daily therapy continued to receive OTEZLA at two years. Improvements in efficacy measures observed at 52 weeks were sustained through 104 weeks of treatment. At week 104, among patients receiving OTEZLA 30 mg twice daily, the ACR20 response rate was 65.3 percent. ACR50 and 70 response rates were 34.0 percent and 19.6 percent, respectively, at week 104. Similar findings were observed in PALACE 4. In this trial, nearly 84 percent of DMARD-naďve patients who completed one year of OTEZLA 30 mg twice daily monotherapy continued to receive OTEZLA at two years. At week 104, among patients treated with OTEZLA 30 mg twice daily monotherapy, an ACR20, 50 and 70 response was reached by 61.4 percent, 40.7 percent and 19.2 percent of patients, respectively. In both PALACE 1 and PALACE 4, changes in other efficacy measures—including the HAQ-DI, which assesses improvements in physical function, and swollen and tender joint counts—were also generally sustained between weeks 52 and 104 with continued OTEZLA treatment. In PALACE 4, treatment with OTEZLA in patients with pre-existing enthesitis or dactylitis, two key manifestations of psoriatic arthritis, resulted in improvements in enthesitis and dactylitis that were sustained through 104 weeks of treatment.
07:04 EDTMANUManchester United reports Q1 EPS GPB5.45 vs. (GPB0.18) last year
Subscribe for More Information
07:03 EDTMANUManchester United sees FY15 revenue GBP385M-GPB395M
Subscribe for More Information
06:34 EDTCSDraghi sees positive signs in euro zone, NY Times reports
Subscribe for More Information
November 17, 2014
10:02 EDTMDASOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:00 EDTHSYHershey management to meet with JPMorgan
Subscribe for More Information
09:24 EDTMDASMedAssets downgraded to Market Perform at Raymond James
Subscribe for More Information
09:00 EDTDGDollar General says now accepting American Express cards
Subscribe for More Information
07:27 EDTMDASMedAssets downgraded to Market Perform from Outperform at Raymond James
Subscribe for More Information
07:16 EDTCELGMilken Institute--Faster Cures to hold a conference
Subscribe for More Information
November 14, 2014
17:07 EDTCELGSoros Fund Management gives quarterly update on stakes
Subscribe for More Information
16:52 EDTDSWGreenlight Capital gives quarterly update on stakes
Subscribe for More Information
15:15 EDTAWAYHomeAway management to meet with FBN Securities
Meeting to be held in Chicago on November 19 hosted by FBN Securities.
15:13 EDTAWAYHomeAway management to meet with Piper Jaffray
Subscribe for More Information
07:14 EDTCELGAmerican College of Rheumatology is holding a meeting
2014 ACR/ARHP Annual Meeting is being held in Boston on November 14-19.
06:16 EDTFIATYEU says Starbucks tax deal in Netherlands may be illegal state aid, WSJ says
The European Union said the tax deal struck by Starbucks (SBUX) in the Netherlands amounts to illegal state aid, reports the Wall Street Journal. European Commission regulators said it reached a preliminary view that the tax deal violated guidelines produced by the Organization for Economic Cooperation and Development. It said the tax deal "tolerates questionable adjustments which allow Starbucks Manufacturing BV to lower the resulting corporate income tax basis in the Netherlands." The EU is also investigating tax arrangements of Apple (AAPL) in Ireland and Amazon (AMZN) and Fiat S.p.A. (FIATY) in Luxembourg. Reference Link
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use